U.S. Medical Equipment Stock News

TAL Education Group reported past first-quarter 2026 results to May 31, with sales of US$758.38 million and net income of US$408.01 million, sharply higher than a year earlier, alongside basic earnings per share from continuing operations of US$0.7367. The combination of much stronger profitability and the extension of its share repurchase plan to July 28, 2027, highlights management’s confidence in the business and capital allocation approach. Next, we’ll examine how this sharp jump in...

Why Steven Madden Stock Is Back On Investors’ Radar Steven Madden (SHOO) has jumped back into focus after reporting stronger second quarter 2026 results, returning to profitability alongside higher revenue and an updated full year growth outlook. See our latest analysis for Steven Madden. The stronger second quarter and updated 2026 outlook have lined up with a clear shift in sentiment, with Steven Madden’s share price showing a 15.64% 1 month share price return and a 24.92% 3 month share...

Deckers Outdoor stock has pulled back this year, yet over 5 years it has still delivered a solid gain, and both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples currently point to the shares trading below what the underlying business might justify. Deckers Outdoor has returned 34.6% over the last 5 years, which suggests the long term shareholder experience has been positive despite recent short term weakness. Future growth in cash flows from its footwear...

The latest class action lawsuits targeting Avis Budget Group (CAR) have put governance and trading conduct in the spotlight for existing and prospective shareholders. These filings center on alleged market manipulation and disclosure issues. See our latest analysis for Avis Budget Group. At a latest share price of $142.18, Avis Budget Group has seen a 1 day share price return of 2.77% and a 7 day share price return of 3.45%, while the 30 day share price return declined 8.97%. The 1 year total...

Frontdoor, Inc. reported past second-quarter 2026 results with sales of US$645 million and net income of US$125 million, alongside updated guidance calling for third-quarter 2026 revenue of US$642 million to US$652 million and full-year 2026 revenue of US$2.19 billion to US$2.21 billion. The company achieved its first organic growth in total ending member count in five years, improved earnings per share, and completed a sizeable share repurchase program totaling 8,882,911 shares for...

Why Avista Stock Is Back On Investors’ Radar Avista (AVA) has drawn fresh attention after reporting higher second quarter net income and earnings per share compared with a year earlier, along with a reaffirmed quarterly dividend that keeps income focused investors watching the stock. See our latest analysis for Avista. Despite the stronger second quarter results and reaffirmed dividend, Avista’s recent share price momentum has been soft, with a 30 day share price return of 7.57% and a 90 day...

Why LegalZoom.com Stock Is Back In Focus LegalZoom.com (LZ) is back on investor radar after its early August earnings update combined several key developments. These included new revenue guidance, detailed M&A intentions, and a substantial share repurchase milestone. See our latest analysis for LegalZoom.com. Despite the new Microsoft 365 Copilot integration, lower full year revenue guidance and ongoing M&A interest, LegalZoom.com’s share price has fallen 39.83% year to date and the 1 year...

What Cheniere Energy Partners earnings mean for investors Cheniere Energy Partners (CQP) reported second quarter 2026 revenue of US$2,583 million and net income of US$1,161 million, with earnings per unit rising versus the same period last year. For the first half of 2026, revenue reached US$6,183 million and net income was US$1,347 million. Basic and diluted earnings per unit from continuing operations were US$2.33, compared with US$1.99 a year earlier. See our latest analysis for Cheniere...

Stock offering and ownership shift at Innovex International The latest move around Innovex International (INVX) centers on a follow on equity offering of 5,000,000 common shares, priced and sold by affiliates of Amberjack Capital Partners rather than the company itself. Innovex International will not receive cash from this transaction, since the selling shareholders are the ones disposing of stock. For you as an investor, the focus is on how this larger freely traded float relates to recent...

Charles River Laboratories International (CRL) has cut its 2026 GAAP earnings guidance and reported a quarterly net loss, after recording divestiture related charges alongside slightly lower revenue compared with the same period last year. See our latest analysis for Charles River Laboratories International. Despite lowering 2026 GAAP EPS guidance and reporting a quarterly net loss, Charles River Laboratories International’s recent share price momentum has been strong, with a 90 day share...

Why Simone Lagomarsino’s Board Appointment Matters For Columbia Banking System Columbia Banking System (COLB) has drawn investor attention after announcing that Simone Lagomarsino will join its Board of Directors on September 1, 2026, with roles on the Enterprise Risk Management and Audit Committees. For a regional bank that operates entirely in the United States, this kind of board change can shape how the company thinks about risk, growth opportunities and oversight. Investors often watch...

Cavco Industries, Inc. reported first-quarter 2027 results on July 30, 2026, with sales rising to US$585.97 million from US$535.69 million a year earlier, while net income and earnings per share declined, and the company continued executing on its share repurchase program. Alongside record revenue and a roughly 50% expansion in backlog that points to strong demand, Cavco’s outlook is being shaped by the recently passed bipartisan ROAD to Housing Act, which is expected to support manufactured...

IDEAYA Biosciences recently reported second-quarter 2026 results, posting US$8.86 million in revenue alongside a wider net loss of US$112.45 million, or US$1.22 per share, while also updating investors on its development programs. A key highlight was the advance of IDE892 into Part 2 monotherapy expansion in its Phase 1/2 trial for MTAP-deleted solid tumors, underscoring progress in an area where there are currently no approved therapies. Against this backdrop, we’ll examine how IDE892’s...

Quanta Services stock has delivered a very large 5 year return, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiple checks currently point to the shares trading at a premium rather than offering clear value. Quanta Services has returned very close to 6x over the past 5 years, which puts extra focus on whether today’s price still offers an attractive entry point. Stronger revenue growth expectations after recent acquisitions can support a higher valuation,...

In recent days, American Eagle Outfitters reported that analysts expect upcoming earnings to show a lower EPS but higher revenue than a year ago, alongside a forward P/E ratio below the industry average and a Zacks Rank #2 (Buy) rating that was assigned before today. This combination of revenue growth expectations, compressed valuation multiples, and favorable analyst ranking has become a focal point for investors reassessing the retailer’s earnings power and positioning in the specialty...

In late July 2026, UniCredit announced a long‑term collaboration with Accenture and IBM to redesign its banking technology model across thirteen European markets, including Accenture acquiring IBM’s majority stake in their joint technology infrastructure joint venture, while IBM supplies modernised platforms like IBM Z, software and consulting, subject to regulatory approvals. A few days earlier, Radisson Hotel Group revealed it had partnered with Accenture to launch an AI-powered hotel...

Affirm Holdings has delivered a very strong 396.4% return over the past three years. However, current valuation checks and the Excess Returns intrinsic value estimate both indicate the stock is trading at a premium to what the fundamentals support. A roughly 396.4% gain over three years highlights how sharply expectations for Affirm Holdings have reset. This raises the bar for what the business needs to deliver next. Expectations for continued growth in Affirm Holdings' buy now, pay later...

Tempus AI (TEM) is back in focus after CellCarta added the company to its CDx Commercialization Lab Network, linking Tempus Hub ordering to CellCarta testing and tightening access to oncology companion diagnostics for U.S. providers. See our latest analysis for Tempus AI. Tempus AI’s recent CellCarta partnership, PRISM2 publication and earnings update have arrived alongside a sharp 1-day share price return of 12.86% and a 7-day share price return of 18.65%. However, the year-to-date share...

Rithm Capital (RITM) reported second quarter 2026 results that gave investors fresh insight into the real estate focused asset manager. Sales reached US$182.13 million and net income was US$56.29 million. See our latest analysis for Rithm Capital. Following the second quarter update, Rithm Capital's share price sits at US$10.19, with a 30 day share price return of 11% and a year to date share price decline of 7.19%, while the 5 year total shareholder return of 69.07% highlights a stronger...

With global food prices sitting at multi year highs in July 2026, many investors are watching headline inflation and missing a quieter story. Lower used car prices and easing inflation in several countries are pointing to gentler price pressures. That can put more attention on companies where cash flows matter most. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that stand out today. The three stocks highlighted below are just a sample. The full...

On August 6, 2026, US Foods Holding Corp. reported higher second-quarter and year-to-date sales and net income, reaffirmed its 2026 net sales growth guidance of 4% to 6%, and completed share repurchases totaling 16,612,155 shares for about US$1.36 billion across two buyback authorizations. The combination of improved earnings, ongoing confidence in full-year performance, and sizable buybacks shrinking the share count highlights management’s focus on both operational execution and capital...

Astera Labs, Inc. reported past second-quarter 2026 results showing sales of US$392.4 million and net income of US$153.09 million, alongside six-month sales of US$700.76 million and net income of US$233.4 million, all substantially higher than a year earlier. Alongside these results, the company issued upbeat third-quarter 2026 guidance, projecting US$540 million to US$560 million in revenue and GAAP diluted EPS of US$0.87 to US$0.92, underscoring management’s confidence in its current AI...

Arcutis Biotherapeutics (ARQT) is back on investor radars after second quarter 2026 results showed revenue of $129.86 million, net income of $15.01 million, and raised full year net product sales guidance. See our latest analysis for Arcutis Biotherapeutics. The latest results and raised full year guidance have come alongside a 19.07% 3 month share price return and a 71.23% 1 year total shareholder return. However, shorter term share price returns over the past month and year to date have...

Why Avery Dennison Stock Is Back in Focus After Q2 Avery Dennison (AVY) is drawing fresh attention after reporting higher Q2 2026 sales and net income, lifting its full-year earnings guidance, continuing its share buyback program, and declaring a new cash dividend. See our latest analysis for Avery Dennison. Avery Dennison’s recent Q2 earnings beat, higher full year guidance, share buybacks and the new dividend have coincided with a 10.25% 1 month share price return and a 6.08% 1 year total...